1995
DOI: 10.1097/00007890-199560120-00028
|View full text |Cite
|
Sign up to set email alerts
|

BONE MARROW-DERIVED DENDRITIC CELL PROGENITORS (NLDC 145+, MHC CLASS II+, B7-1dim, B7-2−) INDUCE ALLOANTIGEN-SPECIFIC HYPORESPONSIVENESS IN MURINE T LYMPHOCYTES1,2

Abstract: The functional maturation of dendritic cells (DC) and other antigen-presenting cells is believed to reflect the upregulation of cell surface major histocompatibility complex (MHC) class II and other T cell costimulatory molecules, especially the CD28 ligands B7-1 (CD80) and B7-2 (CD86). In this study, we propagated cells exhibiting characteristics of DC precursors from the bone marrow (BM) of BIO mice (H_2 b ; I-A +) in response to granulocyte-macrophage colony stimulating factor (GM-CSF). The methods used wer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

8
141
2
2

Year Published

1999
1999
2010
2010

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 265 publications
(153 citation statements)
references
References 45 publications
(47 reference statements)
8
141
2
2
Order By: Relevance
“…2,4 Maximizing the tolerogenic potential of DC by means that may include their genetic manipulation, offers a potential novel approach to the therapy of immune-mediated disorders, including allograft rejection, autoimmune disease and allergy. Indeed, there is already evidence that immature DC, 8,19 or DC exposed to ultraviolet (UV) irradiation 20 or immunosuppressive molecules (such as IL-10, transforming growth factor ␤ (TGF␤), or CTLA4Ig) 19,[21][22][23] have tolerogenic potential. DC that are inherently deficient in cell surface expression of costimulatory molecules can induce T cell hyporesponsiveness in vitro and prolong allograft survival.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…2,4 Maximizing the tolerogenic potential of DC by means that may include their genetic manipulation, offers a potential novel approach to the therapy of immune-mediated disorders, including allograft rejection, autoimmune disease and allergy. Indeed, there is already evidence that immature DC, 8,19 or DC exposed to ultraviolet (UV) irradiation 20 or immunosuppressive molecules (such as IL-10, transforming growth factor ␤ (TGF␤), or CTLA4Ig) 19,[21][22][23] have tolerogenic potential. DC that are inherently deficient in cell surface expression of costimulatory molecules can induce T cell hyporesponsiveness in vitro and prolong allograft survival.…”
Section: Discussionmentioning
confidence: 99%
“…The interaction of CD28 on T cells with B7 ligands on APC provides an essential second signal for T cell activation. [5][6][7] Immature DC, deficient in these molecules (DC progenitors) and that resemble DC freshly isolated from non-lymphoid tissues, can induce antigen-specific T cell anergy in vitro 8 and prolong the survival of cardiac 9 or pancreatic islet allografts. 10 Although these DC exhibit tolerogenic potential, they do not induce permanent graft acceptance.…”
Section: Introductionmentioning
confidence: 99%
“…In this segment is localized Csf3r (colony stimulating factor 3 receptor (granulocyte)) (http://www.informatics.jax.org./). GM-CSF influences MLC response, 6 but no influence of a polymorphism in Csf3r on MLR has been described.…”
Section: Discussionmentioning
confidence: 99%
“…1 Another secondary costimulatory signal is an interaction of CD40 on APC with CD40L on T cell. 2 As the strongest proliferative stimulus is generated by class II incompatibility, the principal MLR responding cells are CD4 + T cells, but other immunoregulatory cells and their products, such as IL-1, IL-6, 3 IL-2, IFN␥, IL-4, 4 IL-10, 5 GM-CSF, 6 NO 7 can quantitatively influence the response. Data about influence of some of these factors are often contradictory.…”
Section: Introductionmentioning
confidence: 99%
“…Studies of DC have been greatly facilitated by their generation from progenitors in bone marrow (BM), spleen or blood [13][14][15]. Most protocols include the growth factor GM-CSF but other factors further induce expression of MHC and costimulatory molecules on the DC [16][17][18]. One such factor is IL-4.…”
Section: Introductionmentioning
confidence: 99%